VISKART

This brand name is authorized in Nigeria.

Active ingredients

The drug VISKART contains one active pharmaceutical ingredient (API):

1
UNII 60W3249T9M - ARTESUNATE
 

Artesunate is a semi-synthetic artemisinin derivative, indicated for the initial treatment of severe malaria in adults and children. The antimalarial mechanism of action of artesunate is generally thought to depend upon activation involving iron-mediated cleavage of the endoperoxide bridge of DHA to generate an unstable organic free radical followed by alkylation, where the free radical binds to malarial proteins leading to destruction of parasite membranes.

 
Read more about Artesunate

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A4-100357 Injection VISKART INJECTION INJ 30 mg 1vial with 2 diluent NF-PP-244271 VISKART INJECTION ARTESUNATE 30MG Each vial contains Artesunate 30mg, Each ampoule contains sodium Bicarbonate USP 5% w/v, Water for Injection USP qs, Each ampoule contains Sodium Chloride USP 0.9% w/v, Water for Injection USP qs A4-100357 Drugs ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS Imported Products 1vialwith2diluent Prescription Only Medicine (POM) 12/10/2021 VISKO PHARMACY LTD, 9/26 UDI ROAD, ASATA, ENUGU STATE, NIGERIA 8060786272 viskopharmacyltd@gmail.com SYSTACARE REMEDIES, VILLAGE & POST OFFICE BALKALAN, MAJITHA ROAD, AMRITSAR, PUNJAB, INDIA, India 28/03/2023
B4-5366 Powder for injection Viskart Injection INJ_PWD 60 mg Powder for Solution for Injection in a vial 28/05/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
P01BE03 Artesunate P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BE Artemisinin and derivatives
Discover more medicines within P01BE03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-100357, B4-5366

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.